ipilimumab
Ipilimumab is a medication used in cancer treatment, specifically for certain types of melanoma, a serious skin cancer. It works by enhancing the body's immune system to recognize and attack cancer cells. By blocking a protein called CTLA-4, ipilimumab helps to stimulate an immune response against tumors.
This drug is often used in combination with other therapies, such as nivolumab, to improve treatment outcomes. Ipilimumab is administered through an injection, and like all medications, it can have side effects, including fatigue, skin rash, and gastrointestinal issues. Regular monitoring by healthcare professionals is essential during treatment.